Physician profile
Marshal Fox
NPI 1093962334
$4,670.05
in general payments reported to CMS, 2019-2025
10 companies · $287 in 2025
The $287 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11.23 · 2020: $123 · 2021: $135 · 2022: $1,110 · 2023: $1,451 · 2024: $1,554 · 2025: $287.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,533 · Consulting Fee: $1,000 · Travel and Lodging: $759.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,532.80 |
| Consulting Fee | $1,000.00 |
| Travel and Lodging | $759.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tri-Anim Health Services, INC. | $2,000.00 | 2022-2023 | |
| Abbott Laboratories | $1,188.73 | 2024 | Aveir |
| Boston Scientific Corporation | $565.66 | 2021-2025 | Farapulse, General - Therapies |
| Biosense Webster, INC. | $327.09 | 2022-2024 | Carto 3 |
| Medtronic, INC. | $226.71 | 2021-2024 | Micra |
| Impulse Dynamics (USA) INC. | $138.99 | 2023 | Optimizer |
| Daiichi Sankyo INC. | $109.33 | 2020 | |
| Zoll Respicardia, INC. | $68.40 | 2023 | Remede System |
| Medtronic Vascular, INC. | $24.44 | 2019-2020 | |
| Stryker Corporation | $20.70 | 2023 | N/A |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marshal Fox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.